BIO Company is a private company. It employs 30 engineers and scientists who are involved with research and development of various biomedical devices. All of the engineers and scientists are highly regarded and highly paid in the field of biomedical research. BIO is 50% owned by Rod Smart, who started the company in Year 3, and 50% owned by a group of venture capitalists who contributed $10 million of equity capital in Year 4 to fund the R&D activity of the group.

On January 1, Year 6, REX Ltd., a public company listed on the TSX Venture Exchange, acquired 100% of the shares of BIO by issuing 5 million of its own shares. Its shares were trading at $4 per share on the date of this transaction.

The balance sheet for BIO on January 1, Year 6, was as follows:

Cash and marketable securities	$ 2,500,000
Property, plant, and equipment (net)	800,000
Development costs	3,000,000
	$ 6,300,000
Liabilities	$ 900,000
Common shares	10,100,000
Deficit	(4,700,000)
	$ 6,300,000

The cash, marketable securities, property, plant and equipment, and liabilities have fair values equal to carrying amounts. Prior to Year 5, all of the research and development costs were expensed. Starting in Year 5, the developments costs were capitalized because the management of BIO felt that they were getting close to patenting some of their products.

The management of REX is aware that BIO will need to be included in REX's consolidated financial statements. The questions below were asked by management concerning these consolidated financial statements.

(a) Will any part of the acquisition cost be allocated to BIO's skilled workers? If so, how will this asset be measured, and how will it be amortized or checked for impairment on an annual basis?

(b) Will any part of the acquisition cost be allocated to identifiable intangible assets? If so, how will this asset be measured, how will it be amortized, and when will it be checked for impairment?

(c) How much of the acquisition cost will be recognized as goodwill, and how will goodwill be evaluated for impairment on an annual basis?